Anika Therapeutics

Anika Therapeutics, Inc. is a global company focused on joint preservation and the development of innovative therapies for orthopedic care. The company specializes in addressing degenerative orthopedic diseases and traumatic conditions through clinically meaningful treatments. Its product portfolio includes solutions for osteoarthritis pain management, regenerative therapies, soft tissue repair, and technologies aimed at preserving bone and joint integrity. Anika Therapeutics collaborates with healthcare providers to understand their needs and create minimally invasive products that enhance patient outcomes and promote active living. The majority of the company's revenue is generated from the United States, reflecting its commitment to improving the quality of life for patients worldwide.

Steve Griffin

CFO

3 past transactions

Parcus Medical

Acquisition in 2020
Parcus Medical, LLC is a manufacturer and distributor of surgical products focused on implants and instrumentation for orthopedic applications. Founded in 2007 and based in Sturgeon Bay, Wisconsin, the company specializes in solutions for sports medicine procedures, providing a range of products including suture anchors, interference screws, graft fixation systems, and various accessories. These products are designed to assist orthopedic surgeons in repairing injuries related to the shoulder, knee, hip, and distal extremities, ultimately helping to restore patients' function and mobility. As of January 2020, Parcus Medical operates as a subsidiary of Anika Therapeutics, Inc.

Arthrosurface

Acquisition in 2020
Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures surface implant curvatures for various joints, including the knee, shoulder, wrist, hip, foot, ankle, and toe, aimed at treating orthopedic conditions stemming from trauma, injury, and arthritis. Arthrosurface's innovative devices are developed with an eye toward preserving native joint anatomy and maintaining normal biomechanics, thus allowing patients to experience improved range of motion and reduced pain. The company emphasizes a quick recovery and return to active lifestyles, enabling individuals to engage in activities such as CrossFit and Powerlifting. Operating through a network of sales representatives and distributors, Arthrosurface continues to make significant strides in joint preservation and replacement technology, contributing to the well-being of patients both in the United States and internationally. As of 2020, Arthrosurface operates as a subsidiary of Anika Therapeutics, Inc.

Fidia Farmaceutici

Acquisition in 2009
Fidia Farmaceutici is an Italian multinational company headquartered in Abano Terme, specializing in the development, manufacturing, and marketing of healthcare and pharmaceutical products. The company boasts a diverse product portfolio, primarily centered around hyaluronic acid (HA) applications in various fields, including joint care, wound healing, ophthalmology, aesthetic treatments, and autologous biological therapies. Fidia Farmaceutici offers an array of products such as sterile, lyophilized injectables, ointments, creams, gels, solid oral formulations, and eye drops, which provide innovative solutions for common medical conditions. Through its comprehensive research and development capabilities, the company aims to address specific needs within the pharmaceutical and biomedical sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.